Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share News

212223242526272829

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

29th Dec 2023 13:01

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets. Read More

Investors to be "cautious" with GSK amid static share price

21st Dec 2023 13:06

(Alliance News) - AJ Bell on Thursday noted "four noteworthy stocks for 2024", but warned investors to be cautious around GSK PLC. Read More

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

18th Dec 2023 10:07

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint. Read More

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

18th Dec 2023 07:55

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays. Read More

PRESS: GSK looks for deals in China as rebuilds relationship

17th Dec 2023 15:16

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China. Read More

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

15th Dec 2023 16:51

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks. Read More

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

15th Dec 2023 16:29

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday. Read More

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

12th Dec 2023 08:22

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59. Read More

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

12th Dec 2023 07:39

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation. Read More

GSK drug gets EU marketing backing for form of endometrial cancer

11th Dec 2023 08:28

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer. Read More

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

11th Dec 2023 07:41

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite. Read More

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

7th Dec 2023 12:54

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value. Read More

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

5th Dec 2023 10:02

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday: Read More

GSK early-stage pipeline in focus ahead of investor event

27th Nov 2023 10:26

(Alliance News) - German bank Berenberg is looking for GSK PLC to shed some light on its "early- to mid-stage pipeline" ahead of an investor event hosted by the pharmaceutical firm later this week. Read More

GSK announces positive results from Blenrep phase 3 blood cancer trial

27th Nov 2023 09:00

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results. Read More

LONDON BROKER RATINGS: RBC cuts HSBC; Liberum cuts Glencore

22nd Nov 2023 09:48

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday: Read More

GSK to begin phase 3 trials of low-carbon Ventolin inhaler in 2024

21st Nov 2023 11:52

(Alliance News) - GSK PLC on Tuesday said it will begin phase 3 trials of a low carbon version of its metered dose inhaler Ventolin using a "next generation" propellant in 2024. Read More

LONDON MARKET CLOSE: FTSE 100 underwhelms as stocks jump after US CPI

14th Nov 2023 17:04

(Alliance News) - European equities jumped in the wake of a cooler-than-expected US inflation reading, which took some sting out of a recent hawkish reassessment of the Federal Reserve interest rate outlook. Read More

GSK hails momelotinib opinion from European Medicines Agency committee

13th Nov 2023 09:47

(Alliance News) - GSK PLC on Monday announced that a European Medicines Agency panel has given a positive opinion recommending momelotinib to treat myelofibrosis patients with anaemia. Read More

UK dividends calendar - next 7 days

9th Nov 2023 15:50

Read More

212223242526272829
FTSE 100 Latest
Value10,436.29
Change71.50